Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Nemcic is far from alone. Robert Krouse is a former DOD contractor who said he worked alongside these vets. He endured two ...

Historically, cancer care largely focused on the fight for survival. Now, thanks to advancements in screening and treatment, many patients are living decades beyond their diagnosis.

Throughout her career, one question has always fascinated Dr. Jennifer Chan — where do things go wrong? Answering that ...

Thorne, 35, is sharing the symptoms he experienced before being diagnosed with a stage four brain tumour in the hope of ...

SHE had up built a business empire by claiming she was curing her brain tumour with ‘nutrition, patience, determination and ...